Hjem › Metastatisk kreft › Washington › Tacoma
Kliniske studier for Metastatisk kreft i Tacoma, WA
9 studier for Metastatisk kreft søker deltakere på steder i og rundt Tacoma (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Providence Regional Cancer System-Lacey, Lacey · 23 mi unna
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
RekruttererFase 3
- Research Site, Puyallup · 8 mi unna
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Northwest Medical Specialties, PLLC, Tacoma
- Northwest Medical Specialties, PLLC, Gig Harbor · 8 mi unna
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi unna
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Tacoma
SLV-154 Treatment of Advanced Cancers
RekruttererFase 1
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- MultiCare Health System, Tacoma
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruttererFase 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 mi unna
- MultiCare Regional Cancer Center, Puyallup · 8 mi unna
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekruttererFase 1/2
- Northwest Medical Specialties, PLLC, Tacoma
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RekruttererFase 1
- Northwest Medical Specialties, Tacoma
Metastatisk kreft-studier i andre byer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andre studier i Tacoma
- Ikke-småcellet lungekreft20 studier
- Brystkreft18 studier
- Ulcerøs kolitt15 studier
- Multipelt myelom13 studier
- Prostatakreft11 studier
- Crohns sykdom11 studier
- Kolorektal kreft9 studier
- Melanom7 studier
- Eggstokkreft7 studier
- Mavekreft6 studier
- Spiserørkreft6 studier
- Kreft (alle typer)6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.